Close Menu

Wellcome Sanger Institute

Researchers from the Wellcome Trust Sanger Institute and elsewhere reported online in the American Journal of Human Genetics yesterday that they have tracked down a new risk gene for osteoarthritis.

The test for Grey Platelet Syndrome is being developed by the NHS Blood and Transplant Centre at the Addenbrooke's Biomedical campus in Cambridge, UK.

Using a so-called pairwise sequentially Markovian coalescent model, researchers from the Wellcome Trust Sanger Institute used information in individual human genomes to gain insights into human population history over hundreds of thousands of years.

Wellcome Trust Sanger Institute's COSMIC

Researchers from the Wellcome Trust Sanger Institute and elsewhere describe how they used formaldehyde-assisted isolation of regulatory elements to focus in on non-coding SNP involved in platelet function within an open chromatin region in platelet-producing megakaryocyte cells.

In Nature, researchers describe the high-throughput approach that they have used to make conditional knockouts of more than 9,000 genes in mouse embryonic stem cells.

The researchers aim to find rearrangements in the small amounts of DNA that leak out from the bone cancer into the bloodstream.

Pages

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.